Global Self-management Telematic Support for Patients With Obstructive Sleep Apnea.
TELESAS
1 other identifier
interventional
60
1 country
2
Brief Summary
This clinical trial compares the usual follow-up to a program of telematic control and self-management in a group of patients with severe obstructive sleep apnea-hypopnea syndrome (OSAHS), few symptoms and treated with continuous positive airway pressure (CPAP). The objective of the intervention is to achieve a CPAP compliance of ≥4 hours per day in at least 90% of the subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2019
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2018
CompletedFirst Posted
Study publicly available on registry
January 4, 2019
CompletedStudy Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2021
CompletedApril 26, 2022
April 1, 2022
1.6 years
October 12, 2018
April 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients with a good CPAP compliance
Percentage of patients with a CPAP compliance ≥4 hours per day. The main objective is to assess if a self-management and telematic control program can increase CPAP compliance getting at least 90% of patients using CPAP ≥4 hours per day.
Six months
Secondary Outcomes (21)
CPAP compliance
Six months
Dropout
Six months
Side effects
Six months
Efficacy of the treatment according to the change in sleepiness
Six months
Efficacy of the treatment according to the change in the frequency of the snoring.
Six months
- +16 more secondary outcomes
Study Arms (2)
Control arm
ACTIVE COMPARATORUsual follow-up in Healthcare System for patients with obstructive sleep apnea and CPAP treatment
Intervention arm
EXPERIMENTALUsual follow-up in the Healthcare System for patients with obstructive sleep apnea and CPAP treatment and a telematic control and self-management program
Interventions
During 6 months with CPAP treatment, patients must complete some questionnaires about the presence of refreshing sleep and side effects with the frequency established, using a computing application. Patients can download this application on their own smartphone but, if they prefer, they can be provided with a tablet during the study with this application installed. A set of variables will be collected using an automatic and wireless transmission from latest generation CPAP to control the CPAP compliance and tolerance. All data will be processed in a platform to generate alarms, which will be controled daily by a researcher, as well as solutions to the problems presented during the monitoring.
According to the SEPAR regulation, patients treated with CPAP should be evaluated by the pulmonologist one month after beginning treatment, every 3 months during the first year, every 6 months during the second year and annually from the third year.
Eligibility Criteria
You may qualify if:
- Patients with a recent diagnostic of OSAHS with AHI≥ 30 and indication of CPAP.
- Age≥ 18 years
- Few symptoms, so that, without hypersomnolence (Epworth sleepiness scale ≤ 10)
- Absence of clinic suspect or confirmation of other sleep pathology
- With interest in the use of new technologies
You may not qualify if:
- Nasal obstruction that prevents the use of CPAP
- Psycho-physical inability to complete questionnaires and carry out the program
- Patients undergoing uvulopalatopharyngoplasty
- Cheyne-Stoke syndrome
- Pregnancy
- Absence of informed consent
- Shift work in the last 3 months and transmeridian trips in the last month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Virgen del Puerto Hospital
Plasencia, Cáceres, 10600, Spain
San Pedro de Alcántara
Cáceres, 10003, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
María Ángeles Sánchez Quiroga
Virgen del Puerto Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2018
First Posted
January 4, 2019
Study Start
June 1, 2019
Primary Completion
December 28, 2020
Study Completion
December 28, 2021
Last Updated
April 26, 2022
Record last verified: 2022-04